uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters ~ Gen-X Will Work with uniQure During an Exclusivity Period to Identify Novel Promoters for uniQure’s Product Portfolio ~ ~ uniQure Receives Option to Acquire Gen-X Business for Use in Gene Therapy ~...

VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B Upon closing, VBI received gross proceeds of $11 million, consisting of an upfront payment and an equity investment at $3.05 per share from Brii BiosciencesVBI is eligible to receive an additional...

GeoVax and Leidos Enter into a Collaboration Agreement on Immunotherapy Research Program Combined Technologies May Yield Therapies for Multiple Cancer Indications  ATLANTA, GA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...

Ormat and Toshiba Sign Strategic Collaboration Agreement RENO, Nev., Oct. 14, 2015 (GLOBE NEWSWIRE) -- and TOKYO, Oct. 15, 2015 -- Ormat Technologies Inc. (NYSE:ORA) and Toshiba Corporation (TOKYO:6502) announced today that the two companies have...